The trend warrants attention, given treatment difficulties and the association with other substance use issues, says lead author of Rutgers Health study.
Nicole Swenarton
Advertisement
Articles by Nicole Swenarton
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
Retatrutide Lowers Albuminuria, Glomerular Pressure in Obesity and CKD
2
Tozorakimab Improves Daily Respiratory Symptoms in COPD: OBERON, TITANIA
3
Kidney Compass: ORIGIN 3 Final eGFR Data for Atacicept in IgA Nephropathy
4
Sibeprenlimab Stabilizes eGFR Over 24 Months in IgA Nephropathy: VISIONARY
5